Dr. Andrea Porpiglia Promoted to Assistant Program Director for Complex General Surgical Oncology Fellowship at Fox Chase Cancer Center

Dr. Porpiglia
Andrea Porpiglia, MD, MSc, FACS, has been promoted to Assistant Program Director for the Complex General Surgical Oncology Fellowship.

PHILADELPHIA (July 27, 2023) — Andrea Porpiglia, MD, MSc, FACS, an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, has been promoted to Assistant Program Director for the Complex General Surgical Oncology Fellowship.

“Dr. Porpiglia has been an instrumental part of teaching the next generation of surgical oncologists to prepare for the challenges of the field,” said Jeffrey Farma, MD, FACS, Interim Chair of the Department of Surgical Oncology. “I have no doubt she will continue to be an extraordinary leader for these fellows in her new role as assistant program director.”

The fellowship is a two-year program endorsed by the Accreditation Council for Graduate Medical Education and the Society of Surgical Oncology. It immerses fellows in a learning environment that gives them a better understanding of surgical decision-making related to all aspects of surgical oncology, as well as the technical management of complex problems.

Porpiglia will join Sanjay Reddy, MD, FACS, Associate Professor in the Department of Surgical Oncology and Program Director of the fellowship, in leading this well-rounded surgical oncology experience.

Porpiglia first came to Fox Chase as a surgical oncology fellow in 2013. After five years of private practice in the greater Philadelphia area, she rejoined Fox Chase in 2020 as an instructor and surgeon.

Her specialties include breast cancer, colorectal cancer, GIST, melanoma, neuroendocrine tumors, sarcoma, skin cancer, and stomach cancer. Her treatment focus is in minimally invasive surgery.

In addition to being recognized as a 2023 Top Doctor by Philadelphia magazine, she was also recognized as a Top Doctor by Main Line Today from 2016 through 2018. She is a member of the American Society of Clinical Oncology, the Association of Women Surgeons, the Pennsylvania Medical Society, and the Society of Surgical Oncology.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427